<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-22T07:57:45Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/17EDB9A3-D6FD-4C64-A24B-348E39043743" ns1:id="17EDB9A3-D6FD-4C64-A24B-348E39043743"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/F22F38DB-CCCD-4C8A-B896-0748F2ECC837" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/AB74CD93-1466-4497-93FB-1EE707768B02" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/AB74CD93-1466-4497-93FB-1EE707768B02" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2025-06-29T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/E285DBE6-574B-4CA2-846F-F7976D5816FB" ns1:rel="FUND" ns1:start="2023-02-01T00:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">10025665</ns2:identifier></ns2:identifiers><ns2:title>Queen Mary University of London and Charco Neurotech Limited KTP 21_22 R4</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Knowledge Transfer Partnership</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>To undertake clinical validation of the feasibility, efficacy and tolerability of the CUE1 medical device for patients with Parkinson's Disease. To enable the design of a formal clinical trial to assess and validate the device in treating drug-resistant features of Parkinson's Disease.</ns2:abstractText></ns2:project>